LOGIN
Adding Liposomal Bupivacaine to Bupivacaine in Interscalene Blocks in Total Shoulder Arthroplasty
March 2023
Adding Liposomal Bupivacaine to Bupivacaine in Interscalene Blocks in Total Shoulder Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparing bupivacaine alone to liposomal bupivacaine plus bupivacaine in interscalene blocks for total shoulder arthroplasty: a randomized, non-inferiority trial.
Reg Anesth Pain Med. 2023 Jan;48(1): 1-6.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eighty patients undergoing total shoulder arthroplasty were included in this non-inferiority trial assessing the non-inferiority of bupivacaine (n=40) vs. liposomal bupivacaine plus bupivacaine (n=40) in interscalene brachial plexus block. The primary outcome of interest was 72-hour opioid consumption. Secondary outcomes of interest included opioid consumption, pain scores at rest, during activity...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.